Stocks
Dianthus Therapeutics, Inc.DNTH
NASDAQHealthcareBiotechnology$74.53
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing antibody therapeutics for complement-driven diseases, including rare autoimmune and inflammatory conditions. Its lead candidate targets complement factor D, with early-stage data drawing attention from investors focused on the immunology space.
52W Range: $32.22-$117.88
Congressional Interest in Dianthus Therapeutics, Inc. (DNTH)
No congressional trades have been disclosed for Dianthus Therapeutics, Inc. (DNTH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading DNTH?
No congressional trades found for this stock.